Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$258,894
in 1 filing, $259K under 10b5-1 plans

Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lenar Aimee J. −$259K President, US Pharma sold 10% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-07-11 ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL Sale −3,968 $24.81 $98K 61,722
2019-06-28 WECHSLER AMY B Director Grant or award +1,263 $25.22 $32K 86,351
2019-06-28 ROBERTSON RUSSEL C Director Grant or award +1,486 $25.22 $37K 91,014
2019-06-28 Paulson John Director Grant or award +1,090 $25.22 $27K 53,535
2019-06-28 DE SCHUTTER RICHARD U Director Grant or award +1,239 $25.22 $31K 271,776
2019-06-24 McKenna Mark C. President, Salix Shares withheld for taxes −1,913 $23.82 $46K 31,529
2019-06-13 ValueAct Holdings, L.P. Director Other disposition −111,440 948,353
2019-06-04 Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER Shares withheld for taxes −6,370 $20.73 $132K 61,444

Page 31 of 31 · 608 trades